Williamsburg, Va – September 8, 2015 – This week the innovative work of ivWatch scientists, engineers and clinicians won top honors in a national competition. During a live competitive event held in Richmond, Virginia, ivWatch was awarded first place in the bioscience sector of the Virginia Velocity business plan competition.
The competition is part of Governor McAuliffe’s strategy for diversifying the state’s economy by encouraging the growth of innovative bioscience and energy companies. ivWatch competed against many worthy bioscience businesses from across the nation, all hoping to prove their value to a panel of judges with strong business and industry expertise.

Following two rounds of competition, ivWatch was identified by the panel as one of two finalists in the bioscience sector to compete for the top award.

“We are honored to be singled out for our commitment to innovation that advances patient safety – and proud to be a part of the new Virginia economy,” said Gary Warren, ivWatch CEO.

In addition to being recognized as the best emerging bioscience company in Virginia, ivWatch will receive a $225,000 cash prize to support the company’s growth plans.

# # #

Leah Moore, Director of Marketing, ivWatch, LLC
1.855.489.2824 ext. 7031

ivWatch Logo White

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.

[fc id='6'][/fc]

You have Successfully Subscribed!

Pin It on Pinterest